Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis
Julia Ewaschuk, Ryan Endersby, David Thiel, Hugo Diaz, Jody Backer, Mang Ma, Thomas Churchill, Karen Madsen – 24 August 2007 – A breakdown in intestinal barrier function and increased bacterial translocation are key events in the pathogenesis of sepsis and liver disease. Altering gut microflora with noninvasive and immunomodulatory probiotic organisms has been proposed as an adjunctive therapy to reduce the level of bacterial translocation and prevent the onset of sepsis.